Cynthia Seidel-Dugan
2021
In 2021, Cynthia Seidel-Dugan earned a total compensation of $1.2M as Chief Scientific Officer at Werewolf Therapeutics.
Compensation breakdown
| Bonus | $165,000 |
|---|---|
| Option Awards | $633,299 |
| Salary | $387,016 |
| Other | $1,406 |
| Total | $1,186,721 |
Seidel-Dugan received $633.3K in option awards, accounting for 53% of the total pay in 2021.
Seidel-Dugan also received $165K in bonus, $387K in salary and $1.4K in other compensation.
Rankings
In 2021, Cynthia Seidel-Dugan's compensation ranked 8,162nd out of 12,415 executives tracked by ExecPay. In other words, Seidel-Dugan earned more than 34.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,162 out of 12,415 | 34th |
Division Manufacturing | 3,612 out of 5,505 | 34th |
Major group Chemicals And Allied Products | 1,606 out of 2,375 | 32nd |
Industry group Drugs | 1,428 out of 2,096 | 32nd |
Industry Pharmaceutical Preparations | 1,061 out of 1,546 | 31st |
Source: SEC filing on April 27, 2023.
Seidel-Dugan's colleagues
We found four more compensation records of executives who worked with Cynthia Seidel-Dugan at Werewolf Therapeutics in 2021.